StreetInsider.com News Articles

The Lovesac Co. (LOVE) PT Lowered to $20 at Canaccord

Thu, 10 Sep 2026 13:31:48 -0400

(Updated - September 10, 2026 1:31 PM EDT)

Canaccord analyst Maria Ripps lowered the price target on The Lovesac Co. (NASDAQ: LOVE) to $20.00 (from $22.00) while maintaining a Buy rating.

The analyst commented: "Lovesac's fiscal Q2 results were in line with expectations, with revenue and adj. EBITDA both within guidance and near consensus, while ~$21M of IEEPA tariff refunds lifted reported GM and EPS well above consensus. Net sales marked the company's highest quarterly total outside a fiscal Q4, with $6K+ configurations growing double digits against a strong prior-year comp on larger setups, premium fabrics, and newer innovations, while the sub-$6K

The Lovesac Co. (LOVE) PT Lowered to $20 at Canaccord

Thu, 10 Sep 2026 13:31:48 -0400

(Updated - September 10, 2026 1:31 PM EDT)

Canaccord analyst Maria Ripps lowered the price target on The Lovesac Co. (NASDAQ: LOVE) to $20.00 (from $22.00) while maintaining a Buy rating.

Cannara secures $80M syndicated credit facility with BMO and TD Bank

Thu, 10 Sep 2026 08:00:42 -0400

Cannara Biotech Inc. (TSX: LOVE, OTCQX: LOVFF, FRA: 8CB0) has entered into an amended and restated syndicated credit agreement with Bank of Montreal and The Toronto-Dominion Bank, expanding its total committed borrowing capacity to $80 million, up from approximately $50 million previously accessible.

The restated facility, entered into by Cannara's operating subsidiary Cannara Biotech (OPS) Inc., consists of a $40 million term loan and a $40 million revolving credit facility. The revolving capacity was increased from $10 million. Both facilities mature on December 31, 2029, extending the debt maturity by two years from the prior date of December 31, 2027.

Bank of

Cannara secures $80M syndicated credit facility with BMO and TD Bank

Thu, 10 Sep 2026 08:00:42 -0400

Bank of

Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth

Thu, 10 Sep 2026 08:00:00 -0400

MONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, the “Company”, “us” or “we”) (TSX: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that its operating subsidiary, Cannara Biotech (OPS) Inc., has entered into an amended and restated syndicated credit agreement (the "Restated Credit Facility") with Bank of Montreal ("BMO") and The Toronto-Dominion Bank ("TD"). The Restated Credit

Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth

Thu, 10 Sep 2026 08:00:00 -0400

Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth

Thu, 10 Sep 2026 08:00:00 -0400

Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth

Thu, 10 Sep 2026 08:00:00 -0400

Form 10-Q Lovesac Co For: Aug 02

Thu, 10 Sep 2026 07:26:00 -0400

si-local-file:///var/storage/secattach/20260910/27045098.html

Form 8-K Lovesac Co For: Sep 10

Thu, 10 Sep 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260910/27044977.html

The Lovesac Company Reports Second Quarter Fiscal 2027 Financial Results

Thu, 10 Sep 2026 07:00:00 -0400

Q2 Net Sales Increased to $161.2M
Record Product Launches On Track for Second Half FY27

STAMFORD, Conn., Sept. 10, 2026 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced financial results for the second quarter of fiscal 2027, which ended August 2, 2026.

Shawn David Nelson, Chief Executive Officer, stated, “Second quarter results reflected a record Q2 performance and came in within our guidance range against a choppy category backdrop.

The Lovesac Company Reports Second Quarter Fiscal 2027 Financial Results

Thu, 10 Sep 2026 07:00:00 -0400

Q2 Net Sales Increased to $161.2M
Record Product Launches On Track for Second Half FY27

Shawn David Nelson, Chief Executive Officer, stated, “Second quarter results reflected a record Q2 performance and came in within our guidance range against a choppy category backdrop.

Cannara Biotech names Nicholas Fozard as CFO

Tue, 01 Sep 2026 08:01:32 -0400

Cannara Biotech Inc. (TSX: LOVE, OTCQX: LOVFF, FRA: 8CB0) has appointed Nicholas Fozard, CPA, as Chief Financial Officer, according to a press release from the Montreal-based cannabis producer. The appointment will take effect upon Fozard's receipt of a Health Canada security clearance.

Fozard brings more than a decade of cannabis finance experience. He previously served as Vice President, Finance at Organigram Global and Senior Vice President, Finance at iAnthus. He began his career at PwC. He holds an MBA from the Kellogg–Schulich Executive MBA Program, a Global Professional Master of Laws from the University of Toronto, and an Honours Bachelor of

Cannara Appoints Nicholas Fozard as Chief Financial Officer

Tue, 01 Sep 2026 08:00:00 -0400

MONTREAL, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, the “Company”, “us” or “we”) (TSX: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced the appointment of Nicholas Fozard, CPA, as Chief Financial Officer. Mr. Fozard's appointment as CFO will take effect upon his receipt of the Health Canada security clearance required of all officers and directors of the

Cannara Appoints Nicholas Fozard as Chief Financial Officer

Tue, 01 Sep 2026 08:00:00 -0400

The Lovesac Company Announces Second Quarter Conference Call Date

Thu, 27 Aug 2026 07:00:00 -0400

STAMFORD, Conn., Aug. 27, 2026 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today announced that its second quarter fiscal 2027 financial results will be released before market open on Thursday, September 10, 2026. The Company will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results.

Investors and analysts interested in participating in the call are invited to dial 877-407-3982 (international callers please dial 201-493-6780) approximately 10 minutes prior to the start of the call. A live audio

The Lovesac Company Announces Second Quarter Conference Call Date

Thu, 27 Aug 2026 07:00:00 -0400

The Lovesac Company Announces Second Quarter Conference Call Date

Thu, 27 Aug 2026 07:00:00 -0400

The Lovesac Company Announces Second Quarter Conference Call Date

Thu, 27 Aug 2026 07:00:00 -0400

Cannara Establishes Automatic Share Purchase Plan

Thu, 13 Aug 2026 08:00:00 -0400

MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, the “Company”, “us” or “we”) (TSX: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“NCIB”) to purchase up to 1,975,642 of its common shares (“Shares”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027,